Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer Agents in Medicinal Chemistry is an academic journal published by Bentham Science Publishers. Its subject area sits at the intersection of medicinal chemistry, pharmaceutical science, cancer biology, and rational drug design, with particular emphasis on the discovery and development of compounds intended to prevent or treat cancer. The journal publishes original research reports and review articles addressing the chemical, pharmacological, biological, and design-related aspects of anticancer agents. The publication began in 2001 under the title Current Medicinal Chemistry – Anti-Cancer Agents. That original title positioned it as a cancer-focused companion or related publication within the Current Medicinal Chemistry journal family. In 2006, it adopted the shorter and more descriptive title Anti-Cancer Agents in Medicinal Chemistry, which it continues to use. The title change reflected its established identity as a dedicated venue for research on anticancer drug discovery rather than a general medicinal-chemistry publication. Its coverage is centered on the rational design and evaluation of therapeutic agents. Relevant work may address small-molecule discovery, structure–activity relationships, molecular targets, mechanisms of action, pharmacological profiles, synthetic approaches, and the optimization of candidate compounds. Review papers provide consolidated accounts of emerging targets, therapeutic strategies, chemical classes, and developments in cancer pharmacotherapy, while research articles report new findings in medicinal chemistry and related disciplines. The journal is part of the international scholarly communication system serving medicinal chemists, pharmaceutical researchers, cancer researchers, pharmacologists, and drug-development specialists. Its content is intended for researchers involved in the identification and optimization of anticancer compounds, as well as readers tracking advances in chemical biology and oncology-oriented drug design. The journal is associated with Current Medicinal Chemistry and is published in English. The editor-in-chief identified in the available reference material is Simone Carradori of the University of Chieti-Pescara, Italy. The journal has also been included in major scholarly abstracting and indexing services, although the available material does not provide a complete current list. Journal Citation Reports recorded an impact factor of 2.8 for 2022; this is a bibliometric indicator rather than a financial or operating measure. No independently verified information is available here about circulation, revenue, subscription figures, ownership beyond its Bentham Science publishing relationship, or the journal's precise editorial office location.

Anti-Cancer Agents in Medicinal Chemistry was established in 2001 as Current Medicinal Chemistry – Anti-Cancer Agents. From its launch, the journal served as a cancer-focused publication connected with the broader Current Medicinal Chemistry portfolio. Its remit combined medicinal chemistry with the discovery and design of chemotherapeutic and other anticancer agents, giving researchers a dedicated venue for findings that might otherwise be distributed across general pharmaceutical, chemical, or oncology journals. In 2006, the publication adopted its present title, Anti-Cancer Agents in Medicinal Chemistry. The new name made its specialization more explicit and established the title used in current bibliographic and publisher references. Under this identity, the journal has continued to focus on chemical approaches to cancer treatment, including the design, synthesis, characterization, and biological evaluation of potential therapeutic agents. The journal's scope covers both primary research and scholarly synthesis. Original papers can report newly developed compounds, medicinal-chemistry optimization programs, target-directed studies, structure–activity relationships, and related pharmacological investigations. Review papers place individual discoveries within broader discussions of cancer targets, therapeutic mechanisms, chemical scaffolds, drug-resistance issues, and emerging approaches to anticancer drug development. This combination allows the journal to function both as a research outlet and as a source of literature reviews for scientists following developments in oncology-oriented drug discovery. Anti-Cancer Agents in Medicinal Chemistry is published by Bentham Science Publishers and is related to Current Medicinal Chemistry. Its intended readership includes medicinal chemists, pharmaceutical scientists, cancer biologists, pharmacologists, and researchers working in preclinical drug discovery. The journal is peer reviewed and has been abstracted and indexed in scholarly databases. Available reference material identifies Simone Carradori of the University of Chieti-Pescara as editor-in-chief. Journal Citation Reports listed a 2022 impact factor of 2.8, providing an externally reported measure of citation performance for that year. The available sources do not establish a precise founding editorial team, a full succession history of editors, a specific headquarters address, subscription or article-processing economics, or detailed changes in publication frequency. Those matters therefore remain unspecified rather than inferred.

• 2022

  Reported impact factor

  [1]Anti-Cancer Agents in Medicinal Chemistryen.wikipedia.org

  Journal Citation Reports recorded an impact factor of 2.8 for the journal in 2022.

• 2006

  Present title adopted

  [1]Anti-Cancer Agents in Medicinal Chemistryen.wikipedia.org

  The journal changed its name to Anti-Cancer Agents in Medicinal Chemistry, the title used in current references.

• 2001

  Journal established under an earlier title

  [1]Anti-Cancer Agents in Medicinal Chemistryen.wikipedia.org

  The publication was launched as Current Medicinal Chemistry – Anti-Cancer Agents, with a dedicated focus on cancer-related medicinal chemistry and drug design.

A specialized international scholarly journal for medicinal chemistry and rational drug-design research related to anticancer agents.

• Peer-reviewed academic journal · 2001

  Anti-Cancer Agents in Medicinal Chemistry

  The core publication is a peer-reviewed journal covering medicinal chemistry and rational drug design in oncology. It publishes original research and review literature on the discovery, synthesis, optimization, biological testing, pharmacology, and mechanisms of anticancer agents. Its audience includes researchers in medicinal chemistry, pharmaceutical science, cancer biology, pharmacology, and preclinical drug development.

• 2006

  Rebranding from Current Medicinal Chemistry – Anti-Cancer AgentsStrategy

  Background

  The journal had originally been established as a cancer-focused title associated with Current Medicinal Chemistry.

  Action taken

  It adopted the more direct title Anti-Cancer Agents in Medicinal Chemistry.

  Aftermath

  The new title clarified the publication's specialization in anticancer medicinal chemistry and remains its current identity.

  Source

1. 1Anti-Cancer Agents in Medicinal Chemistryen.wikipedia.org
2. 2Bentham Science journal pagebenthamscience.com